Coronary artery stenting is now used in many laboratories as the primary therapy for
coronary artery lesions in patients with ischemic heart disease. However, intracoronary
stents are still plagued by a considerable risk of restenosis. 1 Serial intravascular ultrasound
studies suggest that neointimal proliferation through the stent struts, rather than arterial
remodeling, accounts for almost all the late loss in lumen diameter. 2 Recent reports indicate
that inflammatory mechanisms play a crucial role in the pathogenesis of neointimal …